Traws Pharma, Inc.
Current role
TRAW
C. David Pauza
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About C. David Pauza
Traws Pharma, Inc. reported in an 8-K filed April 4, 2024 that C. David Pauza was appointed Chief Scientific Officer, Virology, effective April 1, 2024.
“C. David Pauza was appointed the Company's Chief Scientific Officer, Virology and Robert Redfield was appointed the Company's Chief Medical Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Traws Pharma, Inc. (TRAW)
Proxy statement
Current2024-04-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Traws Pharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Iain D. Dukes CEO, Board Member
- Iain Dukes CEO, Board Member
- Werner Cautreels CEO, Board Member
- Jack E. Stover Chairman
- Jack Stover Chairman
- James J. Marino, JD, MBA Chairman
- Charles Parker CFO
- Nora Brennan CFO
- Nikolay Savchuk COO, Board Member
- Iain Dukes, D.Phil. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.